CALU and neoplasm: Some of these proteins have been identified as tumor inhibitors in some contexts, including calumenin [62], alpha2-macroglobulin [63], myosin II [64], heterogeneous nuclear ribonucleoprotein G [65] and nucleophosmin [66].